Patents & IP

Patents & Intellectual Property

Developing innovative intellectual property in computational biotechnology, AI therapeutics, diagnostic platforms, and scientific software.

Intellectual Property Strategy

Alkhaleeli BioAI LLC is actively developing patentable intellectual property in computational biotechnology. Our patent strategy focuses on novel frameworks, algorithms, and conceptual designs that represent original contributions to the fields of computational biology, AI-guided therapeutics, diagnostic design, and scientific software.

Provisional Concept

mRNA Vaccine Design Frameworks

Computational frameworks for theoretical mRNA vaccine candidate design, including antigen scoring, sequence optimization logic, and manufacturability assessment systems.

In Development

Diagnostic Biosensor Platforms

AI-guided theoretical binding protein and colorimetric biosensor design frameworks for pathogen detection applications.

In Development

Scientific Software Systems

Software platforms for bioinformatics analysis, PDF report generation, sequence scoring, and research workflow automation.

Provisional Concept

Wireless Energy & Biomedical Devices

Conceptual designs for wireless energy systems and biomedical device platforms with novel engineering approaches.

In Development

AI-Guided Therapeutics

Artificial intelligence frameworks for computational therapeutic design, target evaluation, and biomedical decision support systems.

Planned

Biomedical Engineering Systems

Integrated biomedical engineering concepts combining AI, computational modeling, and diagnostic platform design.

Interested in licensing or collaborating on intellectual property?

Contact Us About IP Collaboration
USPTO Filings

USPTO Patent Portfolio & Innovation Filings

Biotechnology • AI Diagnostics • mRNA Research • Biosensors • Energy Innovation

Rami M. Alkhaleeli's innovation portfolio includes one granted U.S. patent and multiple USPTO provisional patent applications across biomedical device design, AI-guided mRNA research, rapid immunoassay concepts, AI-designed biosensor platforms, and magneto-mechanical energy-harvesting technology.

Granted Patent

Method and Apparatus for Improving Osseointegration, Functional Load, and Overall Strength of Intraosseous Implants

US Patent No.11,058,521
GrantedJuly 13, 2021
Assignee / Co-InventorsUniversity of Central Oklahoma — Rami Mohanad Mahdi Alkhaleeli, Vagan Tapaltsyan, Morshed Khandaker, Shahram Riahinezhad, and Niyaf Nidhal Kadhem Alkadhem

Rami M. Alkhaleeli, Founder and CEO of Alkhaleeli BioAI LLC, is a named co-inventor of U.S. Patent No. 11,058,521, assigned to the University of Central Oklahoma. This patent relates to implant-surface technologies designed to improve osseointegration and biological integration. This patent is presented as part of the founder's professional innovation background. It is not represented as intellectual property owned or licensed by Alkhaleeli BioAI LLC. No institutional endorsement or commercial partnership with UCO is implied.

View public patent record
Provisional Filing

AI-guided personalized mRNA cancer vaccines with CRISPR-based antigen validation

Application No.63/936,055
Receipt DateOctober 30, 2025
InventorRami Mohaned Mahdi Alkhaleeli

This provisional filing describes a research-only AI-guided workflow for identifying cancer-associated targets, prioritizing possible mRNA vaccine candidates, and using CRISPR-based concepts for antigen-validation research. This is an early-stage computational and experimental concept, not a clinical treatment or approved vaccine.

Provisional Filing

Lateral Flow Immunoassay Apparatus for Rapid Detection and Quantification of Allergen-Specific IgE Antibodies

Application No.63/931,575
Receipt DateDecember 5, 2025
InventorRami Mohaned Mahdi Alkhaleeli

This provisional filing focuses on a rapid lateral-flow immunoassay concept for detecting and estimating allergen-specific IgE antibodies. The goal is to support fast, accessible allergy-related screening research using a portable test-format concept.

Provisional Filing

Artificial Intelligence Designed Synthetic Binding Protein Colorimetric Biosensor Platform for Rapid Diagnostic Detection and Classification of Gram Negative Bacteria, Gram Positive Bacteria, and Fungal Pathogens

Application No.64/004,904
Receipt DateMarch 13, 2026
InventorRami M. Alkhaleeli

This provisional filing describes an AI-designed biosensor platform using synthetic binding proteins and colorimetric detection concepts to identify and classify bacterial and fungal pathogens. The concept is intended for research and prototype development, not clinical diagnostic use unless validated and cleared by regulators.

Provisional Filing

The Five-Stage Magneto-Mechanical RF Harvester for Battery-Free Phones

Application No.64/017,342
Receipt DateMarch 26, 2026
InventorMr. Rami M. Alkhaleeli

This provisional filing presents an energy-harvesting concept combining magneto-mechanical motion and RF-related energy-capture ideas for battery-free or emergency power applications. It represents early-stage engineering research into alternative micro-power generation.

USPTO Receipts & Patent Records

Important Disclaimer: Some records shown are provisional patent applications and are not issued patents. Provisional applications are early-stage USPTO filings and do not by themselves represent granted patent rights. Medical, scientific, diagnostic, and therapeutic concepts shown here are research-only and are not FDA-cleared, clinically validated, or intended for diagnosis, treatment, cure, or clinical decision-making unless specifically approved through the appropriate regulatory process.

Alkhaleeli BioAI LLC presents this portfolio for informational, educational, and research-innovation purposes. All medical and biotechnology concepts require laboratory validation, safety testing, regulatory review, and appropriate approvals before any clinical or commercial use.